Amitabh Chandra's Research
Selected Research Publications:
Biopharma Venture Capital and The Inflation Reduction Act
Vogel, Matthew, Rena Conti, and Amitabh Chandra. "Biopharma Venture Capital and The Inflation Reduction Act." Health Affairs Forefront, March 5, 2024.
Biotech Asset Valuation Methods: A Practitioner's Guide
Amitabh Chandra and Sumon Mazumdar. "Biotech Asset Valuation Methods: A Practitioner's Guide." Journal of Investment Management, 2024; 22(1): 36-57.
Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act
Vogel, M., Kakani, P., Chandra, A. et al. "Medicare price negotiation and pharmaceutical innovation following the Inflation Reduction Act." Nature Biotechnology (2024).
The Great Resignation, Employment, and Wages in Health Care
Amitabh Chandra and Louis-Jonas Heizlsperger. "The Great Resignation, Employment, and Wages in Health Care." NEJM Catalyst, December 4, 2023.
Cost of Exempting Sole Orphan Drugs from Medicare Negotiation
Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim, Benjamin N. Rome. "Cost of Exempting Sole Orphan Drugs from Medicare Negotiation," JAMA Intern Med. Published online November 27, 2023.
Are Hospital Quality Indicators Causal?
Amitabh Chandra, Maurice Dalton and Douglas Staiger. "Are Hospital Quality Indicators Causal?" National Bureau of Economic Research, Working Paper No.31789, October 2023.
What Does the Inflation Reduction Act Mean for Patients and Physicians?
Amitabh Chandra and Benedic Ippolito. "What Does the Inflation Reduction Act Mean for Patients and Physicians?" NEJM Catalyst Innovations in Care Delivery, 2023; 4(10).
Productivity Variation and Input Misallocation: Evidence from Hospitals
Chandra, Amitabh, Carrie H. Colla, and Jonathan S. Skinner. "Productivity Variation and Input Misallocation: Evidence from Hospitals." HKS Faculty Research Working Paper Series RWP23-024, August 2023.
What Can Economics Say about Alzheimer's Disease?
Amitabh Chandra, Courtney Coile, and Corina Mommaerts. 2023. "What Can Economics Say about Alzheimer's Disease?" Journal of Economic Literature, 61 (2): 428-70.
Concerns about Patient Access to Biopharmaceuticals and Outcomes
Amitabh Chandra and Jay V. Patel. Concerns about Patient Access to Biopharmaceuticals and Outcomes. NEJM Catalyst, January 2023.
Achieving Universal Health Insurance Coverage in the United States: Addressing Market Failures or Providing a Social Floor?
Katherine Baicker, Amitabh Chandra, and Mark Shepard. Achieving Universal Health Insurance Coverage in the United States: Addressing Market Failures or Providing a Social Floor? w30854. National Bureau of Economic Research, January 2023.
Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation
Amitabh Chandra, Jennifer Kao, Kathleen L. Miller, and Ariel D. Stern. Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation. w30712. National Bureau of Economic Research, December 2022.
The Contribution of Price Growth to Pharmaceutical Revenue Growth in the U.S.: Evidence from Medicines Sold in Retail Pharmacies
Pragya Kakani, Michael Chernew, Amitabh Chandra; The Contribution of Price Growth to Pharmaceutical Revenue Growth in the U.S.: Evidence from Medicines Sold in Retail Pharmacies. Journal of Health Politics, Policy, and Law 2022.
Coverage of New Drugs in Medicare Part D
H. Naci, I. Kyriopoulos, W.B. Feldman, T.J. Hwang, A.S. Kesselheim, A. Chandra. Coverage of New Drugs in Medicare Part D. The Milbank Quarterly. May 3, 2022.
Supporting Value-Based Health Care: Aligning Financial and Legal Accountability
Mark M. Zaki, Anupam B. Jena, and Amitabh Chandra. Supporting Value-Based Health Care: Aligning Financial and Legal Accountability. New England Journal of Medicine, September 9, 2021.
The Great Unequalizer: Initial Health Effects of COVID-19 in the United States
Marcela Alsan, Amitabh Chandra, and Kosali I. Simon. The Great Unequalizer: Initial Health Effects of COVID-19 in the United States, w28958, National Bureau of Economic Research, June 2021.
Regulatory Approval and Expanded Market Size
Ben Berger, Amitabh Chandra, and Craig Garthwaite. Regulatory Approval and Expanded Market Size, w28889, National Bureau of Economic Research, June 2021.
The Health Costs of Cost-Sharing
Amitabh Chandra, Evan Flack, and Ziad Obermeyer. The Health Costs of Cost-Sharing, w28439, National Bureau of Economic Research, February 2021.
Hospital Allocation and Racial Disparities in Health Care
Amitabh Chandra, et al. Hospital Allocation and Racial Disparities in Health Care. w28018, National Bureau of Economic Research, 2 Nov. 2020.
What Values and Priorities Mean for Health Reform
Kate Baicker, Amitabh Chandra, New England Journal of Medicine, Massachusetts Medical Society, Sept. 2020, p. e89.
Moving the Financing of Graduate Medical Education into the 21st Century
Grischkan JA, Friedman AB, Chandra A. Journal of the American Medical Association. Published online August 26, 2020.
Allocation of COVID-19 Relief Funding to Disproportionately Black Counties
Kakani P, Chandra A, Mullainathan S, Obermeyer Z. JAMA. Published online August 07, 2020. doi:10.1001/jama.2020.14978
Do We Spend Too Much on Health Care?
Katherine Baicker and Amitabh Chandra, New England Journal of Medicine 383(2020): 605-608
Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S.
Pragya Kakani, Michael Chernew, Amitabh Chandra, National Bureau of Economic Research, w 26846, 2020
Identifying Sources of Inefficiency in Healthcare
Amitabh Chandra, Douglas O Staiger, Identifying Sources of Inefficiency in Healthcare, The Quarterly Journal of Economics, qjz040
Amitabh Chandra is an economist, Ethel Zimmerman Wiener Professor of Public Policy at Harvard Kennedy School, Henry and Allison McCance Family Professor of Business Administration at Harvard Business School, and Director of Health Policy Research at the Harvard Kennedy School of Government, where he is also Director of PhD Admissions and Area Chair for Social and Urban Policy. He is a member of the Congressional Budget Office’s (CBO) Panel of Health Advisors, and is a Research Associate at the IZA Institute in Bonn, Germany and at the National Bureau of Economic Research (NBER). His research focuses on productivity and cost-growth in health care, medical malpractice, and racial disparities in health care. Chandra has testified to the United States Senate and the United States Commission on Civil Rights. His research has been featured in the New York Times, the Washington Post, CNN, Newsweek, and on National Public Radio. He has been a consultant to the RAND Corporation, Microsoft Research, the Institute of Medicine and the Blue Cross Blue Shield Foundation of Massachusetts. In 2011 he served as Massachusetts’ Special Commissioner on Provider Price Reform.
Professor Chandra is an elected member of the Institute of Medicine, the first-prize recipient of the Upjohn Institute’s Dissertation Award, the Kenneth Arrow Award for best paper in health economics, and the Eugene Garfield Award for the impact of medical research. In 2012, he was awarded American Society of Health Economists (ASHE) medal. The ASHE Medal is awarded biennially to the economist age 40 or under who has made the most significant contributions to the field of health economics.